SPES Pharmaceuticals
Pre-clinical505b2 Pharmaceutical | SPES Pharmaceuticals Inc. | United States
Founded
2017
Focus
Small Molecules
About
505b2 Pharmaceutical | SPES Pharmaceuticals Inc. | United States
Funding History
2Total raised: $25M
Series A$20MUndisclosedNov 15, 2022
Seed$5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2017
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile